NDC 0065-0332

PATANASE

Olopatadine Hydrochloride

PATANASE is a Nasal Spray, Metered in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Olopatadine Hydrochloride.

Product ID0065-0332_60a572b8-9ea4-49aa-b76c-05fe2ffefdfc
NDC0065-0332
Product TypeHuman Prescription Drug
Proprietary NamePATANASE
Generic NameOlopatadine Hydrochloride
Dosage FormSpray, Metered
Route of AdministrationNASAL
Marketing Start Date2008-04-28
Marketing CategoryNDA / NDA
Application NumberNDA021861
Labeler NameAlcon Laboratories, Inc.
Substance NameOLOPATADINE HYDROCHLORIDE
Active Ingredient Strength600 ug/1
Pharm ClassesDecreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0065-0332-08

1 BOTTLE in 1 CARTON (0065-0332-08) > 8 SPRAY, METERED in 1 BOTTLE
Marketing Start Date2008-04-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0065-0332-30 [00065033230]

PATANASE SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA021861
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2008-04-28

NDC 0065-0332-08 [00065033208]

PATANASE SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA021861
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-04-28

Drug Details

Active Ingredients

IngredientStrength
OLOPATADINE HYDROCHLORIDE600 ug/1

OpenFDA Data

SPL SET ID:c4cffabd-774b-4cfd-b312-c86cf5206402
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1797895
  • 1797898

    • Pharmacological Class

    • Decreased Histamine Release [PE]
    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Inhibitor [EPC]

    NDC Crossover Matching brand name "PATANASE" or generic name "Olopatadine Hydrochloride"

    NDCBrand NameGeneric Name
    0065-0332PATANASEolopatadine hydrochloride
    0078-0834PATANASEolopatadine hydrochloride
    17478-105OlopatadineOlopatadine Hydrochloride
    17478-305OlopatadineOlopatadine Hydrochloride
    0093-7684Olopatadine HydrochlorideOlopatadine Hydrochloride
    0363-0200OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDE
    0363-8022OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDE
    0378-8023Olopatadine HydrochlorideOlopatadine Hydrochloride
    0065-0272PATADAYolopatadine hydrochloride
    0065-0816PATADAY ONCE DAILY RELIEFOLOPATADINE HYDROCHLORIDE
    0065-8150PATADAY ONCE DAILY RELIEFOLOPATADINE HYDROCHLORIDE
    0065-4274PATADAY TWICE A DAY RELIEFOLOPATADINE HYDROCHLORIDE
    0065-0271Patanololopatadine hydrochloride
    0065-4273Pazeoolopatadine hydrochloride

    Trademark Results [PATANASE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PATANASE
    PATANASE
    78516827 3473648 Dead/Cancelled
    NOVARTIS AG
    2004-11-15
    PATANASE
    PATANASE
    78080521 2635415 Live/Registered
    NOVARTIS AG
    2001-08-22
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.